Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2019-12-03 Purchase | 2019-12-03 6:11 pm | Protagonist Therapeutics Inc | PTGX | Kalkofen Donald A. Chief Financial Officer | 1,175 | $5.0952 | $5,987 | 1,175 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-02-15 Option Award | 2022-02-17 7:26 pm | N/A 2032-02-14 | Protagonist Therapeutics Inc | PTGX | Kalkofen Donald A. Chief Financial Officer | 52,500 | $0 | 63,521 (Direct) | View |
| 2021-02-26 Option Award | 2021-02-26 6:29 pm | N/A 2031-02-25 | Protagonist Therapeutics Inc | PTGX | Kalkofen Donald A. Chief Financial Officer | 62,500 | $0 | 65,386 (Direct) | View |
| 2020-02-28 Option Award | 2020-02-28 5:45 pm | N/A 2030-02-27 | Protagonist Therapeutics Inc | PTGX | Kalkofen Donald A. Chief Financial Officer | 55,000 | $0 | 55,000 (Direct) | View |
| 2019-05-31 Option Award | 2019-06-03 7:40 pm | N/A 2029-05-30 | Protagonist Therapeutics Inc | PTGX | Kalkofen Donald A. Chief Financial Officer | 100,000 | $0 | 100,000 (Direct) | View |